Health Tech: Shane Cooke Of Etiometry On How Their Technology Can Make An Important Impact On Our Overall Wellness
News and Press Releases
An Interview With David Leichner published by Authority Magazine
From discussing the five things every health tech founder should know, to the real-world impact of Etiometry’s technology in the ICU, this piece offers a compelling look into the mission driving our team forward every day. Read the full interview HERE
Related
First FDA-Cleared System Provides Real-Time Data for Cardiogenic Shock
Etiometry was recently featured in a Medscape interview with insights from our co-founder and CTO, Dimitar Baronov, alongside clinicians Walter Schiffer, MD, Cardiologist at Washington University School of Medicine and Srihari Naidu, MD, President of SCAI. The article highlights the importance of early identification in cardiogenic shock and how integrating continuous physiologic data with EHR, […]
Etiometry has been named one of the “Top Most Influential Companies to Watch 2026” by BizTech Outlook.
With recent FDA clearance for the first and only Hospital-Specific Cardiogenic Shock Classification and Tracking tool, we’re expanding how care teams can identify risk earlier and intervene with greater precision. The article highlights how critical care is evolving, using continuous data to help clinicians spot changes sooner and make more informed decisions at the bedside. […]
First Automated Hospital-Specific Cardiogenic Shock Classification Tool for Critical Care Teams
Etiometry has received FDA clearance (K254066) for the Etiometry Cardiogenic Shock Tool: the first-ever automated solution for hospital-specific cardiogenic shock classification and tracking (aligned with each institution’s own protocols) using physiologic monitoring data. This is Etiometry’s 11th FDA clearance overall, and the only solution that automates SCAI staging directly from physiologic monitoring data. For cardiac […]